Late onset Alzheimer's disease in older people
- PMID: 21103401
- PMCID: PMC2981103
- DOI: 10.2147/CIA.S11718
Late onset Alzheimer's disease in older people
Abstract
Dementia has become a common diagnosis in aging populations, and the numbers will increase in the forthcoming years. Alzheimer's disease (AD) is the most common form of dementia in the elderly, accounting for 50%-56% of cases at autopsy and in clinical series. Nowadays, the number of people affected by AD is rapidly increasing, and more than 35 million people worldwide have AD, a condition characterized by deterioration of memory and other cognitive domains, and leading to death 3-9 years after diagnosis. The number of patients with AD, the most common cause of disability in the elderly, is set to rise dramatically. Therefore, it is important for clinicians to recognize early signs and symptoms of dementia and to note potentially modifiable risk factors and early disease markers.
Keywords: Alzheimer disease; dementia; elderly.
Similar articles
-
Clinical practice. Early Alzheimer's disease.N Engl J Med. 2010 Jun 10;362(23):2194-201. doi: 10.1056/NEJMcp0910236. N Engl J Med. 2010. PMID: 20558370 Review. No abstract available.
-
Alzheimer's disease and age-related memory decline (preclinical).Pharmacol Biochem Behav. 2011 Aug;99(2):190-210. doi: 10.1016/j.pbb.2011.02.002. Epub 2011 Feb 24. Pharmacol Biochem Behav. 2011. PMID: 21315756 Free PMC article. Review.
-
[Drug treatment of Alzheimer's dementia : Status quo and perspectives].Internist (Berl). 2019 Jul;60(7):761-768. doi: 10.1007/s00108-019-0625-4. Internist (Berl). 2019. PMID: 31139854 Review. German.
-
Alzheimer's disease: Seeing the signs early.J Am Acad Nurse Pract. 2009 Nov;21(11):588-95. doi: 10.1111/j.1745-7599.2009.00436.x. J Am Acad Nurse Pract. 2009. PMID: 19900220
-
Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621. Geriatr Psychol Neuropsychiatr Vieil. 2016. PMID: 27651011 Review. English.
Cited by
-
The role of innate immunity in Alzheimer's disease.Immunol Rev. 2020 Sep;297(1):225-246. doi: 10.1111/imr.12896. Epub 2020 Jun 26. Immunol Rev. 2020. PMID: 32588460 Free PMC article. Review.
-
CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review.Neurol Ther. 2020 Dec;9(2):419-434. doi: 10.1007/s40120-020-00218-z. Epub 2020 Oct 21. Neurol Ther. 2020. PMID: 33089409 Free PMC article. Review.
-
Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease.bioRxiv [Preprint]. 2023 Dec 22:2023.12.22.573059. doi: 10.1101/2023.12.22.573059. bioRxiv. 2023. Update in: Alzheimers Dement. 2024 Jun;20(6):3987-4001. doi: 10.1002/alz.13851. PMID: 38187571 Free PMC article. Updated. Preprint.
-
Inhibiting the Cholesterol Storage Enzyme ACAT1/SOAT1 in Aging Apolipoprotein E4 Mice Alters Their Brains' Inflammatory Profiles.Int J Mol Sci. 2024 Dec 21;25(24):13690. doi: 10.3390/ijms252413690. Int J Mol Sci. 2024. PMID: 39769453 Free PMC article.
-
The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy.Aging Dis. 2020 Jul 23;11(4):895-915. doi: 10.14336/AD.2019.0927. eCollection 2020 Jul. Aging Dis. 2020. PMID: 32765953 Free PMC article. Review.
References
-
- Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advances. Annu Rev Public Health. 2002;23:213–231. - PubMed
-
- Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the “common” neurologic disorders? Neurology. 2007;68:326–337. - PubMed
-
- Querfurth HW, LaFerla FM. Mechanisms of disease: Alzheimer’s disease. N Engl J Med. 2010;362:329–344. - PubMed
-
- den Dunnen WF, Brouwer WH, Bijlard E, et al. No disease in the brain of a 115-year-old woman. Neurobiol Aging. 2008;29:1127–1132. - PubMed
-
- Drachman DA. Aging of the brain, entropy, and Alzheimer disease. Neurology. 2006;67:1340–1352. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical